A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing

AR Vernon, RM Pemberton, HR Morse - Mutagenesis, 2022 - academic.oup.com
The regulatory 2D in vitro micronucleus (MN) assay is part of a battery of tests, used to test
for genotoxicity of new and existing compounds before they are assessed in vivo (ICH S2) …
被引用次数：4 相关文章

A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing.

AR Vernon, RM Pemberton, HR Morse - Mutagenesis, 2022 - europepmc.org
The regulatory 2D in vitro micronucleus (MN) assay is part of a battery of tests, used to test
for genotoxicity of new and existing compounds before they are assessed in vivo (ICH S2) …

A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing

AR Vernon, RM Pemberton, HR Morse - Mutagenesis, 2022 - pubmed.ncbi.nlm.nih.gov
The regulatory 2D in vitro micronucleus (MN) assay is part of a battery of tests, used to test
for genotoxicity of new and existing compounds before they are assessed in vivo (ICH S2) …
[PDF] oup.com

[PDF][PDF] A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing

AR Vernon, RM Pemberton, HR Morse - Mutagenesis, 2022 - academic.oup.com
The regulatory 2D in vitro micronucleus (MN) assay is part of a battery of tests, used to test
for genotoxicity of new and existing compounds before they are assessed in vivo (ICH S2) …

novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing.

AR Vernon, RM Pemberton, HR Morse - Mutagenesis, 2022 - search.ebscohost.com
The regulatory 2D in vitro micronucleus (MN) assay is part of a battery of tests, used to test
for genotoxicity of new and existing compounds before they are assessed in vivo (ICH S2) …
[HTML] nih.gov

[HTML][HTML] A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing

AR Vernon, RM Pemberton, HR Morse - Mutagenesis, 2022 - ncbi.nlm.nih.gov
The regulatory 2D in vitro micronucleus (MN) assay is part of a battery of tests, used to test
for genotoxicity of new and existing compounds before they are assessed in vivo (ICH S2) …
[PDF] worktribe.com

[PDF][PDF] A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing

AR Vernon, RM Pemberton, HR Morse - Mutagenesis, 2022 - uwe-repository.worktribe.com
The regulatory 2D in vitro micronucleus (MN) assay is part of a battery of tests, used to test
for genotoxicity of new and existing compounds before they are assessed in vivo (ICH S2) …
[PDF] researchgate.net

[PDF][PDF] A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing

AR Vernon, RM Pemberton, HR Morse - Mutagenesis, 2022 - researchgate.net
The regulatory 2D in vitro micronucleus (MN) assay is part of a battery of tests, used to test
for genotoxicity of new and existing compounds before they are assessed in vivo (ICH S2) …
[PDF] researchgate.net

[PDF][PDF] A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing

AR Vernon, RM Pemberton, HR Morse - Mutagenesis, 2022 - researchgate.net
The regulatory 2D in vitro micronucleus (MN) assay is part of a battery of tests, used to test
for genotoxicity of new and existing compounds before they are assessed in vivo (ICH S2) …

A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing.

AR Vernon, RM Pemberton, HR Morse - Mutagenesis, 2022 - europepmc.org
The regulatory 2D in vitro micronucleus (MN) assay is part of a battery of tests, used to test
for genotoxicity of new and existing compounds before they are assessed in vivo (ICH S2) …